Hermetica Superfood Encyclopedia
The Short Answer
Inga edulis leaves contain concentrated epicatechin (25.43 ± 0.14 mg/g dry crude extract) and myricetin-3-rhamnopyranoside (16.51 ± 0.20 mg/g DCE) with high ORAC antioxidant capacity, while seeds yield triterpenoid saponins julibroside A1 and A3 that inhibit RPMI 8226 multiple myeloma cell proliferation in vitro with IC₅₀ values of 0.9 µM and 6.0 µM respectively. All evidence remains limited to in vitro cell-line and phytochemical characterization studies, with no clinical trials, standardized dosing, or bioavailability data yet established in humans.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordInga edulis benefits
Ice Cream Bean — botanical close-up
Health Benefits
**Antioxidant Activity**
Leaf methanol-water extracts provide an ORAC value of 11.16 ± 1.03 mmol TE/g DCE, driven by epicatechin, catechin, and quercetin glycosides that scavenge free radicals and may reduce oxidative stress burden.
**Antiproliferative Potential Against Multiple Myeloma**
Seed saponins julibroside A1 and julibroside A3 demonstrated in vitro inhibition of RPMI 8226 multiple myeloma cell proliferation at IC₅₀ values of 0.9 ± 0.3 µM and 6.0 ± 1.5 µM respectively, suggesting cytotoxic selectivity worthy of further investigation.
**Cytotoxicity Against Glioma Cells**
Fruit peel phenolic acids, predominantly benzoic acid and vanillic acid, exhibited cytotoxicity against T98G human glioblastoma cells with an IC₅₀ of 18.6 µg/mL, consistent with documented antitumor properties of small phenolic acids in cancer cell lines.
**Antimicrobial Activity**
Leaf dichloromethane extracts demonstrated moderate antibacterial activity against Staphylococcus aureus at a minimum inhibitory concentration of 7.0 mg/mL, indicating bioactive defense compounds with potential infection-related applications.
**Polyphenol-Rich Nutritional Profile**
Total phenolic content of leaf extracts reaches 496.5 ± 75.3 mg GAE/g DCE, placing Inga edulis among the more phenolic-dense Amazonian botanicals and suggesting broad secondary metabolite diversity across plant parts.
**Traditional Ethnobotanical Support**
Indigenous communities across Amazonia have long incorporated the fruit, leaves, and bark of Inga edulis into food systems and local medicinal practices, providing historical context for its continued investigation as a source of bioactive phytochemicals.
Origin & History
Natural habitat
Inga edulis is native to the tropical rainforests of South America, particularly the Amazon Basin, and is widely distributed across Peru, Brazil, Ecuador, Colombia, and Central America. The tree thrives in humid lowland environments, tolerating poorly drained and acidic soils, which makes it a valued agroforestry species used to shade crops such as coffee and cacao. Indigenous communities across Amazonia have cultivated and harvested the tree for centuries, primarily for its sweet, cotton-like white pulp surrounding the seeds.
“Inga edulis has been a culturally significant food tree across indigenous Amazonian societies for centuries, with the sweet white pulp of the fruit pod — which has a flavor and texture reminiscent of vanilla ice cream — consumed widely across Peru, Brazil, Ecuador, Colombia, and throughout Central America. The tree carries important agroecological roles in indigenous agricultural systems, planted as a nitrogen-fixing shade tree in traditional polyculture gardens alongside cacao, coffee, and subsistence crops. In Amazonian ethnobotanical traditions, various plant parts including bark, leaves, and seeds have been explored in local medicinal contexts, though specific preparation methods, indications, and historical formulations are poorly documented in English-language scientific literature and require deeper ethnopharmacological investigation. The linalool content noted in indigenous traditional use suggests possible aromatic or calming applications, consistent with linalool's established profile in other botanical traditions, though this has not been systematically studied in Inga edulis specifically.”Traditional Medicine
Scientific Research
The current body of evidence for Inga edulis consists exclusively of in vitro phytochemical and bioactivity studies, with no clinical trials, animal intervention studies, or human observational cohorts identified in the peer-reviewed literature. Key studies include HPLC-based phenolic profiling of leaf extracts with ORAC antioxidant quantification, bioassay-guided fractionation of seed ethanolic extracts yielding 33.4 mg of saponin-rich material tested against RPMI 8226 and HT-29 cell lines, and fruit peel partition studies evaluating cytotoxicity against T98G glioma cells. No study has reported in vivo pharmacokinetics, bioavailability, or absorption data for any compound isolated from this species, and concentration-response relationships established in cell lines cannot be extrapolated to human therapeutic contexts without bridging studies. Overall, the evidence base qualifies as early-stage preclinical, providing proof-of-concept for bioactive potential but insufficient to support health claims or supplemental recommendations.
Preparation & Dosage
Traditional preparation
**Traditional Whole Fruit Consumption**
The white, sweet pulp surrounding seeds is eaten fresh off the pod; no dose standardization applies to this traditional food use.
**Leaf Methanol-Water Extract (Research Grade)**
3 mg GAE/g DCE total phenolics
Used at unspecified concentrations in antioxidant assays; no human dose established. Crude extract preparations in research yielded 496.5 ± 75..
**Seed Ethanolic Extract (In Vitro)**
Bioassay-guided fractions applied at 20 µg/mL in cell proliferation assays; no translatable human equivalent dose available.
**Fruit Peel Partition Extract (In Vitro)**
Tested against glioma cells at IC₅₀ of 18.6 µg/mL from n-hexane/MeOH fractions; no supplemental form exists.
**No Standardized Supplement Form Currently Available**
No commercial capsule, powder, tincture, or standardized extract of Inga edulis has been validated or documented in the scientific literature as of available research.
Nutritional Profile
The fruit pulp of Inga edulis is primarily composed of simple sugars responsible for its characteristic sweetness, with modest fiber content from the pod walls; detailed macronutrient analyses are not consistently reported in phytochemical literature. Leaf dry crude extracts are exceptionally rich in polyphenolics, with total phenolic content of 496.5 ± 75.3 mg GAE/g DCE; identified compounds include gallic acid, catechin (9.67 ± 0.80 mg/g DCE), epicatechin (25.43 ± 0.14 mg/g DCE), myricetin-3-rhamnopyranoside (16.51 ± 0.20 mg/g DCE), quercetin-3-glucopyranoside, and quercetin-3-rhamnopyranoside. Seeds contain triterpenoid saponins including concinnoside D, julibroside A1, and julibroside A3, while fruit peel yields benzoic acid (approximately 8 mg per 900 mg peel) and vanillic acid (approximately 7 mg per 900 mg peel). Anthocyanins and their derivatives have also been detected in fruit tissues, contributing additional antioxidant capacity; bioavailability of any of these compounds from oral ingestion of whole plant material or extracts has not been characterized.
How It Works
Mechanism of Action
Leaf polyphenols including epicatechin, catechin, gallic acid, myricetin-3-rhamnopyranoside, and quercetin glycosides exert antioxidant effects primarily through hydrogen atom transfer and single electron transfer mechanisms, directly neutralizing reactive oxygen species as measured by ORAC assay. Seed-derived triterpenoid saponins julibroside A1 and A3 are hypothesized to impair cancer cell proliferation through mechanisms related to their enhanced hydrophilicity, which may facilitate cellular membrane disruption and intracellular uptake, leading to cytotoxic effects in RPMI 8226 myeloma lines; however, precise molecular targets such as specific kinase inhibition or apoptotic pathway activation have not been delineated for this species. Fruit peel phenolics including benzoic acid and vanillic acid likely contribute to cytotoxicity via mechanisms analogous to structurally related phenolic acids — including mitochondrial membrane disruption, inhibition of nucleic acid synthesis, or induction of oxidative stress within tumor cells — though species-specific mechanistic data is absent. No receptor binding studies, transcriptomic analyses, or enzyme inhibition assays have been reported for any Inga edulis extract, leaving molecular target identification as a significant gap in the current literature.
Clinical Evidence
No clinical trials have been conducted on Inga edulis in any form, and no human pharmacological data exists for its isolated or crude extracts. All quantified outcomes derive from cell-line proliferation assays — specifically RPMI 8226 multiple myeloma cells, HT-29 colorectal adenocarcinoma cells, and T98G glioblastoma cells — where IC₅₀ values in the sub-micromolar to low microgram per milliliter range were established under controlled in vitro conditions. Effect sizes observed in these cellular models are not translatable to clinical effect sizes without absorption, distribution, metabolism, and excretion data. Confidence in any therapeutic benefit for human consumers remains very low; Inga edulis should be regarded strictly as a candidate ingredient for further preclinical and eventually clinical research.
Safety & Interactions
No adverse effects, systemic toxicity, or dose-limiting side effects have been reported for Inga edulis in any published study, though this reflects the absence of human trials rather than confirmed safety. A comet assay conducted on a related Inga species extract found no genotoxicity, providing limited but modestly reassuring preliminary data on genetic safety; no equivalent genotoxicity study has been published specifically for Inga edulis. No drug interaction studies exist, and interactions with anticoagulants, cytochrome P450 substrates, or immunosuppressive agents cannot be ruled out given the saponin and polyphenol content. No guidance is available for use during pregnancy or lactation, and in the absence of clinical safety data, consumption beyond traditional food use of the fruit pulp should be approached with caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
pacayInga (Inga edulis)joaquiniquilguabaice cream beanInga edulis
Frequently Asked Questions
What are the main bioactive compounds in Inga edulis?
The leaves of Inga edulis are richest in polyphenols, with epicatechin at 25.43 ± 0.14 mg/g dry crude extract, myricetin-3-rhamnopyranoside at 16.51 ± 0.20 mg/g, and catechin at 9.67 ± 0.80 mg/g, alongside quercetin glycosides and gallic acid. Seeds contain triterpenoid saponins julibroside A1, julibroside A3, and concinnoside D, while fruit peel yields benzoic acid and vanillic acid as its primary phenolic acids.
Does Inga edulis have anticancer properties?
In vitro studies show that seed saponins julibroside A1 and A3 inhibit RPMI 8226 multiple myeloma cell proliferation with IC₅₀ values of 0.9 µM and 6.0 µM, and fruit peel extract shows cytotoxicity against T98G glioblastoma cells at IC₅₀ of 18.6 µg/mL. These findings are preliminary cell-line results only; no animal studies or human clinical trials have been conducted, so anticancer claims in humans cannot be supported at this time.
Is there a recommended dose for Inga edulis supplements?
No standardized supplemental dose has been established for Inga edulis in any form, as all research to date has been conducted in laboratory cell-line models using crude extracts at concentrations such as 20 µg/mL. No commercial supplement has been validated, and without human pharmacokinetic or clinical trial data, it is not possible to recommend an evidence-based dose.
Is Inga edulis safe to eat or use medicinally?
The fruit pulp of Inga edulis has a long history of safe consumption as a traditional food across Amazonia and Central America with no documented adverse effects. However, medicinal use of concentrated leaf, seed, or peel extracts lacks formal human safety evaluation, and no drug interaction studies, contraindication data, or pregnancy safety assessments have been published.
What traditional uses does Inga edulis have among indigenous peoples?
Inga edulis has been cultivated and consumed by indigenous Amazonian communities for centuries primarily as a food tree, valued for the sweet white pulp of its fruit pods. The tree also plays an important agroforestry role as a nitrogen-fixing shade plant in traditional polyculture systems; while anecdotal ethnobotanical reports suggest medicinal uses of bark and leaves, specific traditional formulations and indications are not well documented in the scientific literature.
What is the difference between Ice Cream Bean leaf extracts and seed extracts for health benefits?
Ice Cream Bean leaves are rich in antioxidant polyphenols like epicatechin, catechin, and quercetin glycosides, with an ORAC value of 11.16 ± 1.03 mmol TE/g DCE that helps neutralize free radicals. The seeds, by contrast, contain unique saponins (julibroside A1 and A3) that have demonstrated antiproliferative activity against multiple myeloma cells in laboratory studies. Choosing between them depends on whether your primary goal is general antioxidant support (leaves) or targeted research-backed bioactivity (seeds).
How does Ice Cream Bean's antioxidant capacity compare to other tropical herbs?
Ice Cream Bean leaf extracts deliver an ORAC value of 11.16 ± 1.03 mmol TE/g DCE, placing it among moderately potent plant antioxidants driven by polyphenol content. This antioxidant strength is primarily attributed to epicatechin, catechin, and quercetin glycosides, which are also found in high-quality green tea and cacao. The actual antioxidant benefit depends on extraction method and bioavailability, as ORAC values measure test-tube activity rather than absorption in the human body.
What does current research reveal about Ice Cream Bean's effectiveness for multiple myeloma?
In vitro studies have shown that seed saponins julibroside A1 and A3 inhibit the growth of RPMI 8226 multiple myeloma cancer cells in laboratory conditions. However, these findings are preliminary and have not yet been validated in human clinical trials or animal models, so efficacy in living patients remains unproven. More research is needed to determine whether these promising laboratory results translate to therapeutic potential in actual cancer treatment.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ice-cream-bean-inga-edulis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
